Among patients previously treated with @ TNF inhibitor , sustained ustekinumab efficacy was also observed ( week @ combined vs placebo : ACR@ @ % vs @ % , PASI@ @ % vs @ % , median HAQ-DI change -@ vs @ ; week @ ustekinumab-treated : ACR@ @ % , PASI@ @ % , median HAQ-DI change -@ ) .